Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F22%3A00077727" target="_blank" >RIV/00159816:_____/22:00077727 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14310/22:00127468
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S075333222200854X?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S075333222200854X?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.biopha.2022.113465" target="_blank" >10.1016/j.biopha.2022.113465</a>
Alternative languages
Result language
angličtina
Original language name
Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma
Original language description
Drug efficacy determined in preclinical research is difficult to transfer to clinical practice. This is mainly due to the use of oversimplified models omitting the effect of the tumor microenvironment and the presence of various cell types participating in the formation of tumors in vivo. In this study, we used robust three-dimensional models including spheroids grown from colon cancer cell lines and organotypic cultures prepared from the colorectal carcinoma tissue to test novel therapeutic strategies. We developed a multi-modal approach combining bright-field and fluorescence microscopy for evaluating drug effects on organotypic cultures. Combined treatment with 5-fluorouracil and disulfiram/copper efficiently eliminated cancer cells in these 3D models. Moreover, disulfiram/copper down-regulated the expression of markers associated with 5-fluorouracil resistance, such as thymidylate synthase and CD133/CD44. Thus, we propose combined therapy of 5-fluorouracil and disulfiram/copper for further testing as a treatment for colorectal carcinoma. In addition, we show that organotypic cultures are suitable models for anti-cancer drug testing.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30100 - Basic medicine
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Biomedicine & Pharmacotherapy
ISSN
0753-3322
e-ISSN
1950-6007
Volume of the periodical
153
Issue of the periodical within the volume
September
Country of publishing house
US - UNITED STATES
Number of pages
15
Pages from-to
nestrankovano
UT code for WoS article
000878127600004
EID of the result in the Scopus database
—